Global Isosorbide Mononitrate Market Professional Survey Report 2019
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Isosorbide Mononitrate Quarterly Market Size Analysis
- 2.1 Isosorbide Mononitrate Business Impact Assessment - COVID-19
- 2.1.1 Global Isosorbide Mononitrate Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Isosorbide Mononitrate Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Isosorbide Mononitrate Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Isosorbide Mononitrate Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Isosorbide Mononitrate Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Isosorbide Mononitrate Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Isosorbide Mononitrate Market
- 3.5 Key Manufacturers Isosorbide Mononitrate Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Isosorbide Mononitrate Segments, By Type
- 4.1 Introduction
- 1.4.1 10 mg Tablet
- 1.4.2 20 mg Tablet
- 4.2 By Type, Global Isosorbide Mononitrate Market Size, 2019-2021
- 4.2.1 By Type, Global Isosorbide Mononitrate Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Isosorbide Mononitrate Price, 2020-2021
5 Impact of Covid-19 on Isosorbide Mononitrate Segments, By Application
- 5.1 Overview
- 5.5.1 Treatment of angina pectoris
- 5.5.2 Others
- 5.2 By Application, Global Isosorbide Mononitrate Market Size, 2019-2021
- 5.2.1 By Application, Global Isosorbide Mononitrate Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Isosorbide Mononitrate Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Teva
- 7.1.1 Teva Business Overview
- 7.1.2 Teva Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.1.3 Teva Isosorbide Mononitrate Product Introduction
- 7.1.4 Teva Response to COVID-19 and Related Developments
- 7.2 Merck
- 7.2.1 Merck Business Overview
- 7.2.2 Merck Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.2.3 Merck Isosorbide Mononitrate Product Introduction
- 7.2.4 Merck Response to COVID-19 and Related Developments
- 7.3 Nesher Pharmaceuticals
- 7.3.1 Nesher Pharmaceuticals Business Overview
- 7.3.2 Nesher Pharmaceuticals Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.3.3 Nesher Pharmaceuticals Isosorbide Mononitrate Product Introduction
- 7.3.4 Nesher Pharmaceuticals Response to COVID-19 and Related Developments
- 7.4 Taj pharmaceutical
- 7.4.1 Taj pharmaceutical Business Overview
- 7.4.2 Taj pharmaceutical Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.4.3 Taj pharmaceutical Isosorbide Mononitrate Product Introduction
- 7.4.4 Taj pharmaceutical Response to COVID-19 and Related Developments
- 7.5 AMRI
- 7.5.1 AMRI Business Overview
- 7.5.2 AMRI Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.5.3 AMRI Isosorbide Mononitrate Product Introduction
- 7.5.4 AMRI Response to COVID-19 and Related Developments
- 7.6 Intas Pharmaceuticals
- 7.6.1 Intas Pharmaceuticals Business Overview
- 7.6.2 Intas Pharmaceuticals Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.6.3 Intas Pharmaceuticals Isosorbide Mononitrate Product Introduction
- 7.6.4 Intas Pharmaceuticals Response to COVID-19 and Related Developments
- 7.7 Sandoz
- 7.7.1 Sandoz Business Overview
- 7.7.2 Sandoz Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.7.3 Sandoz Isosorbide Mononitrate Product Introduction
- 7.7.4 Sandoz Response to COVID-19 and Related Developments
- 7.8 Globus Remedies
- 7.8.1 Globus Remedies Business Overview
- 7.8.2 Globus Remedies Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.8.3 Globus Remedies Isosorbide Mononitrate Product Introduction
- 7.8.4 Globus Remedies Response to COVID-19 and Related Developments
- 7.9 Intas Pharmaceuticals
- 7.9.1 Intas Pharmaceuticals Business Overview
- 7.9.2 Intas Pharmaceuticals Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.9.3 Intas Pharmaceuticals Isosorbide Mononitrate Product Introduction
- 7.9.4 Intas Pharmaceuticals Response to COVID-19 and Related Developments
- 7.10 Shandong Fangming Pharmaceutical Group
- 7.10.1 Shandong Fangming Pharmaceutical Group Business Overview
- 7.10.2 Shandong Fangming Pharmaceutical Group Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.10.3 Shandong Fangming Pharmaceutical Group Isosorbide Mononitrate Product Introduction
- 7.10.4 Shandong Fangming Pharmaceutical Group Response to COVID-19 and Related Developments
- 7.11 ReYoung Pharmaceutical
- 7.11.1 ReYoung Pharmaceutical Business Overview
- 7.11.2 ReYoung Pharmaceutical Isosorbide Mononitrate Quarterly Production and Revenue, 2020
- 7.11.3 ReYoung Pharmaceutical Isosorbide Mononitrate Product Introduction
- 7.11.4 ReYoung Pharmaceutical Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Isosorbide Mononitrate Supply Chain Analysis
- 8.1.1 Isosorbide Mononitrate Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Isosorbide Mononitrate Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Isosorbide Mononitrate Distribution Channels
- 8.2.2 Covid-19 Impact on Isosorbide Mononitrate Distribution Channels
- 8.2.3 Isosorbide Mononitrate Distributors
- 8.3 Isosorbide Mononitrate Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Isosorbide Mononitrate, including the following market information:
Global Isosorbide Mononitrate Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Isosorbide Mononitrate Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Isosorbide Mononitrate Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
Global Isosorbide Mononitrate Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)
Key market players
Major competitors identified in this market include Teva, Merck, Nesher Pharmaceuticals, Taj pharmaceutical, AMRI, Intas Pharmaceuticals, Sandoz, Globus Remedies, Intas Pharmaceuticals, Shandong Fangming Pharmaceutical Group, ReYoung Pharmaceutical, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
10 mg Tablet
20 mg Tablet
Based on the Application:
Treatment of angina pectoris
Others